Author Question: A mother is distraught that her 13-year-old son weighs 260 pounds and continues to gain weight. She ... (Read 58 times)

sc00by25 · **on:** Jul 23, 2018

A mother is distraught that her 13-year-old son weighs 260 pounds and continues to gain weight. She has asked her family's primary care provider if her child would be a candidate for treatment with orlistat, which she read about on the Internet.

What fact should primarily guide the care provider's decision? A) Orlistat is not approved for use in children under the age of 18.
B) Orlistat can only be administered to children in an inpatient setting.
C) Alternatives such as increased activity and decreased caloric intake should first be exhausted.
D) The drug is not likely to be effective until the boy completes puberty.

Question 2

An elderly patient with a long-standing history of schizophrenia has been admitted to the hospital for treatment of hyponatremia.

The nurse reviews the patient's medical chart and reads that the patient was previously treated with phenothiazine antipsychotics. What medication may this patient have been treated with? A) Aminophylline (Theophylline)
B) Acetylsalicylic acid (aspirin)
C) Chlorpromazine (Thorazine)
D) Dantrolene sodium (Dantrium)

chevyboi1976 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

C
Feedback:
Although experts do not generally recommend drug therapy for treatment of childhood obesity, the FDA has approved orlistat for use in children aged 12 and older and considers the drug to be safe and effective for weight reduction in overweight adolescents. Orlistat is not limited to inpatient use, and puberty does not negate efficacy.

Answer to Question 2

C
Feedback:
Chlorpromazine (Thorazine) is the prototype phenothiazine. Aminophylline (Theophylline) is a xanthine agent administered to increase bronchioles. Acetylsalicylic acid (aspirin) and dantrolene sodium (Dantrium) are not phenothiazines.